A delegation from the Management Committee of the Xixian New Area visited and conducted a research tour at Guorui Yinuo.


On the afternoon of June 7, 2022, Chen Hui, member of the Party Working Committee and deputy director of the Management Committee of Xixian New Area, Wang Bin, director of the Bureau of New Economy of Xixian New Area, Yang Bo, member of the Party Committee and deputy director of the Management Committee of Airport New City, and relevant officials from the Qin Chuangyuan Airport Work Department of Xixian New Area visited and conducted a research tour at Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. Chen Mai, chairman of the board, and Su Lai, general manager, of Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd., accompanied the visit and research.

During the research visit, Chairman Chen Xiang introduced in detail to Deputy Director Chen Hui and his delegation from the Management Committee the laboratory’s development history and future plans, and invited the leaders to tour the experimental platforms for reproductive toxicology, genetic toxicology, analytical testing, clinical diagnostics, and pathological diagnosis.

As an enterprise with the attributes of a Qin Chuangyuan achievement transformation platform, Guo Rui Yinuo will remain committed to upholding integrity while fostering innovation. By building on comprehensive and cutting-edge research, we will create a core engine that drives future transformations in the pharmaceutical industry, thereby contributing to steady and sustainable socio-economic development. We will empower Shaanxi Province to elevate its drug R&D capabilities, enhance its independent innovation capacity in the pharmaceutical sector, and accelerate industrialization reforms and high-quality economic and social development.